Efficacy of Immunotherapy in Treating Metastatic Melanoma: A Randomized Controlled Trial
Immunotherapy provides a superior therapeutic option for patients with metastatic melanoma, offering improved survival outcomes with manageable toxicity. Further research is needed to refine patient selection and optimize treatment combinations.
Authors
- Rahul Tiwari (ORCID: https://orcid.org/0000-0003-4156-776X)
- Vikesh Kumar R Shah
- Ashok Kumar (ORCID: https://orcid.org/0000-0001-9002-6324)
- Akriti Mahajan
- M.A. Khokhar
- Smit Thakkar
- Maariyah Arsheen
Institutions
- Northeastern University (US)
- Government Medical College, Amritsar (IN)
- Manubhai Patel Dental College and Hospital (IN)
- Diabetes Care & Hormone Clinic (IN)
- Government Medical College (IN)
- Sankalchand Patel University (IN)
- M. P. Shah Medical College (IN)
- Institute of Medical Sciences (IN)
Publication Details
- Journal
- Journal of Pharmacy And Bioallied Sciences
- Published
- 2025-02-28
- DOI
- https://doi.org/10.4103/jpbs.jpbs_1475_24
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00